BILITECH
Cell Therapy Solutions for Biliary Disease &
Disorders
Introduction
- A cellular therapy platform for using primary cells to repair and replace diseased tissues and organs.
- Advancing the huge potential of organoid technology in regenerative medicine.
- A University of Cambridge spin out.
- Beach head therapeutic market: Cholanglopathy
Flagship product: BiliDuct
- Self regenerating bioengineered organ structure
- To surgically replace damaged or diseased large bile ducts
- Proof of Concept in large animals
Pipeline product: BiliCell
-
Injectable cellular therapy derived from primary cells to repair a diseased organ
-
To repair diseased bile ducts inside the liver
-
Proof-of-principle: small animals and human organs
Personnel & Credentials Section
Kourosh Saeb-Parsy
CEO
Credential information
Kym Denny
CEO
Credential information
Name Goes Here
Position
Credential information
Name Goes Here
Position
Credential information